WorldPharmaNews
  • Home
  • Business
  • Research
  • Events
  • Regulatory

EMEA recommends withdrawal of the marketing authorisations for lumiracoxib-containing medicines

Details
Research
14 December 2007
The European Medicines Agency (EMEA)The European Medicines Agency (EMEA) has recommended the withdrawal of the marketing authorisations for all lumiracoxib-containing medicines, because of the risk of serious side effects affecting the liver. Lumiracoxib is a non-steroidal anti-inflammatory drug (NSAID) that belongs to the group 'COX-2 inhibitors'. It is used for symptomatic relief in the treatment of osteoarthritis of the hip and knee.
Read more ...

5. In the Absence of Direct-to-Consumer Advertising, Online Content Is Critical

Details
Research
12 December 2007
Manhattan Research, LLCEuropean consumers have been a longneglected piece of the strategic puzzle for most marketers at health and pharmaceutical companies. Yet, signs increasingly point to the degree to which European consumers are, in fact, researching health information and treatment options, and ultimately taking action as a result of those information searches - as outlined in the trend above.
Read more ...

4. Empowered European Consumers Speak with Their Physician about Information Found Online

Details
Research
12 December 2007
Manhattan Research, LLCThe Internet's role is increasing in the patient-physician relationship and having an impact on which treatment decisions are being implemented. Still, the physician clearly remains the ultimate voice on this front. Be they the "cyberchondriacs" or the "cyber savvy," consumers in Europe are turning to the Internet for self-education, symptom checking, prescription medication comparisons, and disease education.
Read more ...

3. Online Physician Portals Evolve into Clinical Resources, Beyond News

Details
Research
12 December 2007
Manhattan Research, LLCTraditionally, physicians relied primarily on local content sources for online medical information, such as DiarioMedico in Spain and Doctors.net in the UK. One notable exception of a site that has transcended the country divides has been the Univadis portal from MSD (Merck Sharp & Dohme).
Read more ...

2. Leverage E-detailing as a Sales Force Supplement

Details
Research
12 December 2007
Manhattan Research, LLCWhile the market for electronic detailing in the U.S. has reached nearly a point of saturation at roughly half of all practicing physicians, the European market is still in an early stage of development and adoption. In fact, only 15% of European physicians have participated in an electronic detailing program today, a number that has remained statistically stagnant year over year.
Read more ...

1. Connecting to Physicians, on Their Terms

Details
Research
12 December 2007
Manhattan Research, LLCTraditionally, pharmaceutical companies had a limited array of sources available to them to communicate with physicians - the sales force, dinner meetings, conferences, and sponsorships. But today's European physician is media savvy and interested in receiving content from a wide variety of professional information and clinical news sources.
Read more ...

European Pharmaceutical Marketing in 2008

Details
Research
12 December 2007
Manhattan Research, LLCCybercitizen® Health Europe is a syndicated multi-client study and advisory service focused on key research topics and trends impacting the European consumer health marketplace. The study was fielded online among 4,302 European consumers from the United Kingdom, Germany, Spain, Italy, France, Belgium, Sweden, the Netherlands, Poland and Portugal. The survey instrument was presented in the native language of each individual country.
Read more ...

More Pharma News ...

  1. Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis
  2. Thomson Scientific Launches Thomson Innovation
  3. eHealth Initiative's Connecting Communities for Drug Safety Collaboration
  4. Common Application for Orphan Designation for Medicines
  5. French scientists identify possible new target for obesity treatment
  6. Results of a Survey of Parents' Perceptions of the Duration of their Child's ADHD Medication
  7. Web Site Helps Alleviate Stress Associated with Caring for Children with Diabetes During the Holiday
  • Start
  • Prev
  • 306
  • 307
  • 308
  • 309
  • 310
  • 311
  • 312
  • 313
  • 314
  • 315
  • Next
  • End

Business & Industry

  • Novartis shares Zolgensma long-term data demonstrating sustained durability up to 7.5 years post-dosing; 100% achievement of all assessed milestones in children treated prior to SMA symptom onset
  • CPHI Pharma Awards open to global innovators, scientists, entrepreneurs and social leaders
  • Insilico Medicine brings AI-powered "ChatPandaGPT" to its target discovery platform
  • BlueRock Therapeutics to incorporate wearable and invisible contactless digital health technologies from Rune Labs and Emerald Innovations in Parkinson's disease clinical trial
  • Novartis Tafinlar + Mekinist approved by FDA for pediatric patients with BRAF V600E low-grade glioma

Research & Development

  • Candidate found to inhibit malignant melanoma growth
  • A nasal spray protects against coronavirus infection - Effective also against recent immune-evasive variants
  • 'Biohybrid' device could restore function in paralysed limbs
  • Scientists use tardigrade proteins for human health breakthrough
  • DNA treatment could delay paralysis that strikes nearly all patients with ALS
  • Scientists reveal a potential new approach to treating liver cancer
  • Normalizing tumor blood vessels may improve immunotherapy against brain cancer

Conferences & Events

  • SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
  • SAE Media Group's 6th annual 3D Cell Culture Conference
  • CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
  • 14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
  • CPHI Excellence in Pharma Award Winners 2022
  • CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
  • CPHI Frankfurt 2022: Global pharma confidence hits record high in the annual CPHI Pharma Index

Regulatory Affairs

  • FDA grants Accelerated Approval for Alzheimer's disease treatment
  • FDA approves new HIV drug for adults with limited treatment options
  • FDA approves first gene therapy for the treatment of high-risk, non-muscle-invasive bladder cancer
  • FDA approves first gene therapy to treat adults with Hemophilia B
  • FDA approves first treatment for Acid Sphingomyelinase Deficiency, a rare genetic disease
  1. You are here:  
  2. Home
  3. Research

About

  • Home
  • Advertise
  • Privacy
  • Cookie Preferences
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2023. All Rights Reserved.